What Are the Long-Term Safety Profiles of Dual Incretin Agonists?
Dual incretin agonists have a well-characterized long-term safety profile consistent with GLP-1 RAs, primarily involving manageable, transient GI effects.
∞ Tirzepatide
∞ Metabolic Health
∞ Side Effects